MacroGenics, Inc.
COMPOUND TARGETING IL-23A AND TNF-ALPHA AND USES THEREOF
Last updated:
Abstract:
The disclosure relates to compounds specific for IL23A and TNF-alpha, compositions comprising the compounds, and methods of use thereof. Nucleic acids, cells, and methods of production related to the compounds and compositions are also disclosed.
Status:
Application
Type:
Utility
Filling date:
26 Aug 2020
Issue date:
25 Feb 2021